Chemoinformaics analysis of 2-Methoxy-1-(9H-pyrido(3,4-b)indol-1-yl)ethanone
| Molecular Weight | 240.262 | nRot | 3 |
| Heavy Atom Molecular Weight | 228.166 | nRig | 16 |
| Exact Molecular Weight | 240.09 | nRing | 3 |
| Solubility: LogS | -3.709 | nHRing | 2 |
| Solubility: LogP | 1.884 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 35.1855 |
| nHD | 1 | BPOL | 16.3525 |
| QED | 0.716 |
| Synth | 2.355 |
| Natural Product Likeliness | 0.229 |
| NR-PPAR-gamma | 0.263 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.834 |
| MDCK | 0.0000177 |
| BBB | 0.949 |
| PPB | 0.815466 |
| VDSS | 1.432 |
| FU | 0.15659 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.265 |
| CYP2c19-sub | 0.412 |
| CYP2c9-inh | 0.134 |
| CYP2c9-sub | 0.375 |
| CYP2d6-inh | 0.218 |
| CYP2d6-sub | 0.61 |
| CYP3a4-inh | 0.323 |
| CYP3a4-sub | 0.253 |
| CL | 4.554 |
| T12 | 0.284 |
| hERG | 0.021 |
| Ames | 0.729 |
| ROA | 0.928 |
| SkinSen | 0.55 |
| Carcinogencity | 0.402 |
| EI | 0.972 |
| Respiratory | 0.985 |
| NR-Aromatase | 0.876 |
| Antiviral | Yes |
| Prediction | 0.713924 |